Literature DB >> 11675094

Variation in European antibiotic use.

S Coenen, M M Kuyenhoven, C C Butler, P Van Royen, T J Verheij.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11675094     DOI： 10.1016/S0140-6736(01)06364-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Overcoming resistance.

Authors:  Caroline Hadley
Journal:  EMBO Rep       Date:  2004-06       Impact factor: 8.807

Review 2.  Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.

Authors:  W T M Jansen; J T van der Bruggen; J Verhoef; A C Fluit
Journal:  Drug Resist Updat       Date:  2006-06-27       Impact factor: 18.500

3.  Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial.

Authors:  Ineke Welschen; Marijke M Kuyvenhoven; Arno W Hoes; Theo J M Verheij
Journal:  BMJ       Date:  2004-08-05

4.  Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial.

Authors:  Christopher C Butler; Sharon A Simpson; Frank Dunstan; Stephen Rollnick; David Cohen; David Gillespie; Meirion R Evans; M Fasihul Alam; Marie-Jet Bekkers; John Evans; Laurence Moore; Robin Howe; Jamie Hayes; Monika Hare; Kerenza Hood
Journal:  BMJ       Date:  2012-02-02

5.  Diagnostic labelling as determinant of antibiotic prescribing for acute respiratory tract episodes in general practice.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; Hanneke M Tiebosch; François G Schellevis; Theo J M Verheij
Journal:  BMC Fam Pract       Date:  2007-09-20       Impact factor: 2.497

6.  Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing.

Authors:  Samuel Coenen; Barbara Michiels; Paul Van Royen; Jean-Claude Van der Auwera; Joke Denekens
Journal:  BMC Fam Pract       Date:  2002-09-09       Impact factor: 2.497
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.